NCT06164327 2023-12-11Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaBeBetter Med IncPhase 1 Unknown75 enrolled
NCT03736616 2022-07-22Acalabrutinib Plus RICE for Relapsed/Refractory DLBCLSwedish Medical CenterPhase 2 Unknown47 enrolled